DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Diabetic Ulcers are a serious complication that can lead to serious complications for those that suffer from them, but there ...

Cardiovascular disease remains the foremost cause of morbidity and mortality globally, affecting millions of individuals. Recent discoveries illuminate the substantial role of genetics in ...

As the American Heart Association states, having high blood sugar levels can damage various parts of the body, increasing the ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

Vascular Leg Pain Claudication is pain, cramping, or heaviness in the legs during physical activity, particularly walking up ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET. Company Participants. Matthew Kreps - Investor Relations Jeffrey Soinski - Chief Executiv ...

Endologix announced final 36-month results for the DETOUR2 study evaluating its Detour system for treating peripheral ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Interventional cardiologist Dr. Ross Melvin joins us to give a demonstration of the new technology available to treat peripheral arterial disease.

Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...